GSK2981278
GSK2981278 is a potent and selective RORγ inverse agonist. GSK2981278 inhibits activation of the il17 promoter and interferes RORγ-DNA binding[1].
Product Specifications
CAS Number
1474110-21-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ROR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ROR-gama-modulator-1.html
Concentration
10mM
Purity
99.51
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CC(C)CN(S(=O)(C1=CC=C(OCC2CCOCC2)C(CO)=C1)=O)C3=CC=C(CC)C=C3
Molecular Formula
C25H35NO5S
Molecular Weight
461.61
Precautions
H302, H315, H319, H335
References & Citations
[1]Smith SH, et al. Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin. PLoS One. 2016 Feb 12;11 (2) :e0147979.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
P21 / WAF1 (WA-1), CF405S conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF640R conjugate, 0.1mg/mL
